Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium ...Middle East

PR Newswire - News
Final results from inspIRE study demonstrate 80% freedom from atrial arrhythmia recurrence at 12 months in patients with optimal Pulsed Field Ablation applications First look results from admIRE study suggests similar outcomes IRVINE, Calif., Feb. 2, 2024 /PRNewswire/ -- Biosense Webster,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium )

Apple Storegoogle play

Also on site :